Related Experiment Video
Updated: Aug 8, 2026
08:31
Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Pyomyositis during induction chemotherapy for acute lymphoblastic leukemia
Kai-Liang Kao1, Giun-Yi Hung, Betau Hwang
1Department of Pediatrics, Taipei Veterans General Hospital, Taipei, Taiwan, ROC. gkl.123@yahoo.com.tw
Journal of the Chinese Medical Association : JCMA
|May 13, 2006
Summary
Pyomyositis, a rare complication in children with acute lymphoblastic leukemia (ALL), presents diagnostic challenges due to symptom overlap with vincristine treatment. This case highlights successful diagnosis and treatment strategies for this difficult condition.
Area of Science:
- Pediatric Oncology
- Infectious Diseases
- Musculoskeletal Disorders
Background:
- Pyomyositis is a rare bacterial infection of muscle, posing diagnostic challenges, especially in immunocompromised pediatric patients.
- Acute lymphoblastic leukemia (ALL) treatment involves immunosuppressive chemotherapy, increasing susceptibility to infections like pyomyositis.
Observation:
- A 10-year-old girl with ALL presented with symptoms mimicking vincristine side effects, delaying pyomyositis diagnosis.
- Initial symptoms of pyomyositis, such as localized pain, are often mistaken for common chemotherapy side effects.
Findings:
- Prompt diagnostic procedures, including imaging and microbiological analysis, were crucial for identifying pyomyositis.
- Effective treatment involved a combination of appropriate antibiotics and surgical intervention where necessary.
Implications:
- Early recognition and prompt management of pyomyositis are vital for favorable outcomes in pediatric ALL patients.
- This case underscores the importance of considering rare infections in immunocompromised children presenting with atypical symptoms.
- Developing improved diagnostic algorithms can mitigate delays and improve treatment efficacy for pyomyositis in ALL patients.
